-
1دورية أكاديمية
المؤلفون: Vincenza Conteduca, Emanuela Scarpi, Paola Caroli, Cristian Lolli, Giorgia Gurioli, Nicole Brighi, Giulia Poti, Alberto Farolfi, Amelia Altavilla, Giuseppe Schepisi, Federica Matteucci, Giovanni Paganelli, Ugo De Giorgi
المصدر: Molecular Oncology, Vol 16, Iss 2, Pp 538-548 (2022)
مصطلحات موضوعية: choline PET/TC, metabolic activity, metastatic castration‐resistant prostate cancer, plasma tumour DNA, prognosis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2
المؤلفون: Amelia Altavilla, Emanuela Scarpi, Federica Matteucci, Alberto Farolfi, Paola Caroli, Giovanni Paganelli, Cristian Lolli, Giorgia Gurioli, Ugo De Giorgi, Vincenza Conteduca, Giuseppe Schepisi, Nicole Brighi, Giulia Poti
المساهمون: Conteduca V., Scarpi E., Caroli P., Lolli C., Gurioli G., Brighi N., Poti G., Farolfi A., Altavilla A., Schepisi G., Matteucci F., Paganelli G., De Giorgi U.
المصدر: Molecular Oncology
Università degli studi di Foggia-IRIS
Molecular Oncology, Vol 16, Iss 2, Pp 538-548 (2022)مصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_specialty, Treatment outcome, Standardized uptake value, metabolic activity, choline PET/TC, metastatic castration-resistant prostate cancer, plasma tumour DNA, prognosis, NO, chemistry.chemical_compound, Prostate cancer, Internal medicine, Genetics, medicine, Enzalutamide, Humans, Liquid biopsy, Neoplasm Metastasis, RC254-282, Survival analysis, Research Articles, Aged, medicine.diagnostic_test, business.industry, Liquid Biopsy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, metastatic castration‐resistant prostate cancer, General Medicine, medicine.disease, Functional imaging, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, chemistry, Positron emission tomography, Molecular Medicine, business, Research Article
وصف الملف: ELETTRONICO
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4282b2f862a524a76a8c0c6e37e4dd5e
https://hdl.handle.net/11392/2472562 -
3
المؤلفون: Enrique Gonzalez-Billalabeitia, Daniel Wetterskog, Francesca Demichelis, Federica Matteucci, Giovanni Paganelli, Giorgia Gurioli, Gerhardt Attard, Giuseppe Schepisi, Chiara Casadei, Ugo De Giorgi, Anna Wingate, Alessandro Romanel, Emanuela Scarpi, Anuradha Jayaram, Cristian Lolli, Delila Gasi Tandefelt, Vincenza Conteduca
المصدر: British Journal of Cancer
Università degli studi di Foggia-IRISمصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_specialty, matastasis, Predictive markers, Article, NO, Androgen deprivation therapy, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Antigen, Interquartile range, Internal medicine, Medicine, Humans, cancer, Prospective Studies, Pseudoprogression, 030304 developmental biology, Aged, Aged, 80 and over, 0303 health sciences, business.industry, Plasma tumour DNA, cancer, prostate cancer, matastasis, Odds ratio, DNA, Neoplasm, Prostate-Specific Antigen, medicine.disease, prostate cancer, Plasma tumour DNA, Confidence interval, Prostatic Neoplasms, Castration-Resistant, 030220 oncology & carcinogenesis, Androstenes, business, Progressive disease
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a97257727a8011e17c9f7588b01c8c7
http://hdl.handle.net/11392/2427036 -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
المؤلفون: Conteduca V; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Unit of Medical Oncology and Biomolecular Therapy, Department of Medical and Surgical Sciences, University of Foggia, Policlinico Riuniti, Italy., Scarpi E; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Scientifico Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Caroli P; Nuclear Medicine Operative Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Lolli C; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Gurioli G; Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Brighi N; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Poti G; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy., Farolfi A; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Altavilla A; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Schepisi G; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Matteucci F; Nuclear Medicine Operative Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Paganelli G; Nuclear Medicine Operative Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.
المصدر: Molecular oncology [Mol Oncol] 2022 Jan; Vol. 16 (2), pp. 538-548. Date of Electronic Publication: 2021 Nov 09.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE